S Aydemir1, D Dogan1, A Kocak2, N Dilsiz3. 1. Faculty of Sciences and Arts, Department of Molecular Biology, Inonu University, Malatya, Turkey. 2. Faculty of Medicine, Department of Neurosurgery, Inonu University, Malatya, Turkey. 3. Faculty of Sciences, Department of Molecular Biology, Harran University, Sanlıurfa, Turkey.
Abstract
STUDY DESIGN: Experimental animal model to assess ischemic spinal cord injury (SCI) following occlusion of the thoraco-abdominal aorta. OBJECTIVES: In the present study, we aimed to investigate the role of melatonin on SCI induced by ischemia and following reperfusion. SETTING: Animal Research Laboratory, Inonu University, Malatya, Turkey. METHODS: We evaluated oxidative damage and caspase-3 activity. In total, 32 adult Wistar albino rats were divided into four groups: Group 1, control (n=8); Group 2 (n=8), those subjected to ischemia/reperfusion (IR) by clamping the thoraco-abdominal aorta; Group 3 (n=8), melatonin (50 mg kg(-1)) treated; and Group 4 (n=8), melatonin (50 mg kg(-1)) followed by ischemia. All animals were kept alive for 48 h, and then spinal cord samples were removed. We assayed oxidative damage by measuring malondialdehyde (MDA), apoptosis by measuring activated caspase-3 (using immunoblots) and intrinsic antioxidative capacity by measuring reduced glutathione (GSH) levels in the spinal cord. RESULTS: The results indicated a significant decrease in activity of caspase-3 in SCI animals after treatment with melatonin, as it significantly decreased the formation of MDA and decelerated the loss of GSH. CONCLUSION: This study suggested that melatonin could be an effective neuroprotective agent for treatment of SCI.
STUDY DESIGN: Experimental animal model to assess ischemic spinal cord injury (SCI) following occlusion of the thoraco-abdominal aorta. OBJECTIVES: In the present study, we aimed to investigate the role of melatonin on SCI induced by ischemia and following reperfusion. SETTING: Animal Research Laboratory, Inonu University, Malatya, Turkey. METHODS: We evaluated oxidative damage and caspase-3 activity. In total, 32 adult Wistar albino rats were divided into four groups: Group 1, control (n=8); Group 2 (n=8), those subjected to ischemia/reperfusion (IR) by clamping the thoraco-abdominal aorta; Group 3 (n=8), melatonin (50 mg kg(-1)) treated; and Group 4 (n=8), melatonin (50 mg kg(-1)) followed by ischemia. All animals were kept alive for 48 h, and then spinal cord samples were removed. We assayed oxidative damage by measuring malondialdehyde (MDA), apoptosis by measuring activated caspase-3 (using immunoblots) and intrinsic antioxidative capacity by measuring reduced glutathione (GSH) levels in the spinal cord. RESULTS: The results indicated a significant decrease in activity of caspase-3 in SCI animals after treatment with melatonin, as it significantly decreased the formation of MDA and decelerated the loss of GSH. CONCLUSION: This study suggested that melatonin could be an effective neuroprotective agent for treatment of SCI.
Authors: M Li; V O Ona; M Chen; M Kaul; L Tenneti; X Zhang; P E Stieg; S A Lipton; R M Friedlander Journal: Neuroscience Date: 2000 Impact factor: 3.590
Authors: R V Rao; E Hermel; S Castro-Obregon; G del Rio; L M Ellerby; H M Ellerby; D E Bredesen Journal: J Biol Chem Date: 2001-07-11 Impact factor: 5.157
Authors: Supriti Samantaray; Eric A Sribnick; Arabinda Das; Varduhi H Knaryan; D Denise Matzelle; Anil V Yallapragada; Russel J Reiter; Swapan K Ray; Naren L Banik Journal: J Pineal Res Date: 2007-12-13 Impact factor: 13.007
Authors: Katarina Bimbova; Maria Bacova; Alexandra Kisucka; Jaroslav Pavel; Jan Galik; Peter Zavacky; Martin Marsala; Andrea Stropkovska; Jana Fedorova; Stefania Papcunova; Jana Jachova; Nadezda Lukacova Journal: Int J Mol Sci Date: 2018-04-07 Impact factor: 5.923